Publicação
Epilepsy in neurodegenerative diseases: related drugs and molecular pathways
| Resumo: | Epilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological disease, with 50 million people affected around the world, and 30% of all epilepsies do not respond to available treatments. Currently, the main hypothesis about the molecular processes that trigger epileptic seizures and promote the neurotoxic effects that lead to cell death focuses on the exacerbation of the glutamate pathway and the massive influx of Ca2+ into neurons by different factors. However, other mechanisms have been proposed, and most of them have also been described in other neurodegenerative diseases, such as Alzheimers disease, Parkinsons disease, Huntingtons disease, or multiple sclerosis. Interestingly, and mainly because of these common molecular links and the lack of effective treatments for these diseases, some antiseizure drugs have been investigated to evaluate their therapeutic potential in these pathologies. Therefore, in this review, we thoroughly investigate the common molecular pathways between epilepsy and the major neurodegenerative diseases, examine the incidence of epilepsy in these populations, and explore the use of current and innovative antiseizure drugs in the treatment of refractory epilepsy and other neurodegenerative diseases. |
|---|---|
| Autores principais: | Cano, Amanda |
| Outros Autores: | Fonseca, Elena; Ettcheto, Miren; Sánchez-López, Elena; de Rojas, Itziar; Alonso-Lana, Silvia; Morató, Xavier; Souto, Eliana B.; Toledo, Manuel; Boada, Mercè; Marquié, Marta; Ruíz, Agustín |
| Assunto: | Epilepsy Neurodegenerative diseases Alzheimers disease Parkinsons disease Huntingtons disease Multiple sclerosis |
| Ano: | 2021 |
| País: | Portugal |
| Tipo de documento: | artigo |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade do Minho |
| Idioma: | inglês |
| Origem: | RepositóriUM - Universidade do Minho |
Registos relacionados
school Caregivers´ and healthcare professionals´ perspectives on caregivers´ burden on neurodegenerative diseases
por: Santos, Joana Filipa dos
Publicado em: (2023)
por: Santos, Joana Filipa dos
Publicado em: (2023)
school Use of ipscs for the treatment of neurodegenerative diseases
por: Serra, Catarina Ferreira Mendes
Publicado em: (2019)
por: Serra, Catarina Ferreira Mendes
Publicado em: (2019)
article Cannabidiol in neurological and neoplastic diseases: Latest developments on the molecular mechanism of action
por: Ozarowski, M.
Publicado em: (2021)
por: Ozarowski, M.
Publicado em: (2021)
article Caffeine and adenosine
por: Ribeiro, Joaquim A.
Publicado em: (2010)
por: Ribeiro, Joaquim A.
Publicado em: (2010)
article Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases
por: Cano, Amanda
Publicado em: (2020)
por: Cano, Amanda
Publicado em: (2020)
article Biodegradable nanoparticles for the treatment of epilepsy: from current advances to future challenges
por: Bonilla, Lorena
Publicado em: (2022)
por: Bonilla, Lorena
Publicado em: (2022)
article Histopathological characterization of cerebral small vessel disease in epilepsy patients with temporal lobe epilepsy submitted to surgery: a case–control study
por: Coelho, Pedro
Publicado em: (2023)
por: Coelho, Pedro
Publicado em: (2023)
article Neurotensins and their therapeutic potential: research field study
por: Kan Yeung, Andy Wai
Publicado em: (2020)
por: Kan Yeung, Andy Wai
Publicado em: (2020)
article Delivering a disease-modifying treatment for Huntington’s disease
por: Godinho, Bruno M. C.
Publicado em: (2015)
por: Godinho, Bruno M. C.
Publicado em: (2015)
article Epigallocatechin-3-gallate PEGylated poly(lactic-co-glycolic) acid nanoparticles mitigate striatal pathology and motor deficits in 3-nitropropionic acid intoxicated mice
por: Cano, Amanda
Publicado em: (2020)
por: Cano, Amanda
Publicado em: (2020)
book The neurodegenerative potential of chronic stress: a link between depression and Alzheimer's disease
por: Sotiropoulos, I.
Publicado em: (2015)
por: Sotiropoulos, I.
Publicado em: (2015)
article Novel concept of exosome-like liposomes for the treatment of Alzheimer's disease
por: Fernandes, Mário
Publicado em: (2021)
por: Fernandes, Mário
Publicado em: (2021)
book Nanotechnology and nature-sourced ingredients for tackling neurodegenerative diseases
por: Rocha, Verónica Patrícia Moreira
Publicado em: (2024)
por: Rocha, Verónica Patrícia Moreira
Publicado em: (2024)
article Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington’s disease decades before clinical motor diagnosis
por: Scahill, Rachael I.
Publicado em: (2025)
por: Scahill, Rachael I.
Publicado em: (2025)
article A biocompatible and injectable hydrogel to boost the efficacy of stem cells in neurodegenerative diseases treatment
por: Ferreira, Helena Susana Costa Machado
Publicado em: (2021)
por: Ferreira, Helena Susana Costa Machado
Publicado em: (2021)
article Huntington’s disease Clinical Trials Corner: January 2019
por: Rodrigues, Filipe Brogueira
Publicado em: (2019)
por: Rodrigues, Filipe Brogueira
Publicado em: (2019)
article Huntington’s disease Clinical Trials Corner: February 2018
por: Rodrigues, Filipe Brogueira
Publicado em: (2018)
por: Rodrigues, Filipe Brogueira
Publicado em: (2018)
article Short-term exposure to particulate matter and effects on emergency hospital admissions for Alzheimer’s disease and Parkinson’s disease: an ecological study from an aged European metropolis
por: Franco, Pedro
Publicado em: (2023)
por: Franco, Pedro
Publicado em: (2023)
school O microbioma e as doenças neurodegenerativas: doença de parkinson
por: Loição, Lilite Mariline Conceição
Publicado em: (2020)
por: Loição, Lilite Mariline Conceição
Publicado em: (2020)
article Diagnostic delay in amyotrophic lateral sclerosis
por: Gwathmey, Kelly G.
Publicado em: (2023)
por: Gwathmey, Kelly G.
Publicado em: (2023)
school Immunotherapy for treatment of central nervous system disorders
por: Coelho, Teresa Paula Castanho
Publicado em: (2015)
por: Coelho, Teresa Paula Castanho
Publicado em: (2015)
book Glucocorticoids and neurodegeneration
por: Vyas, Sheela
Publicado em: (2015)
por: Vyas, Sheela
Publicado em: (2015)
article Going the extra (synaptic) mile: excitotoxicity as the road toward neurodegenerative diseases
por: Armada-Moreira, Adam
Publicado em: (2020)
por: Armada-Moreira, Adam
Publicado em: (2020)
article A new perspective for the treatment of Alzheimer’s Disease: exosome-like liposomes to deliver natural compounds and RNA therapies
por: Ribeiro, Joana
Publicado em: (2023)
por: Ribeiro, Joana
Publicado em: (2023)
school Study of the neuroprotective activity of medicinal plants in Caenorhabditis elegans models of neurodegenerative diseases
por: Fernandes, Jorge Humberto Esperança
Publicado em: (2021)
por: Fernandes, Jorge Humberto Esperança
Publicado em: (2021)
school The role of signaling lipids in the nervous system physiology and pathology: mechanistic insights of the phospholipase D pathway in neurodegenerative diseases
por: Bravo, Ana Francisca Rodrigues Vaz
Publicado em: (2018)
por: Bravo, Ana Francisca Rodrigues Vaz
Publicado em: (2018)
article Fifteen years of clinical trials in Huntington’s disease: a very low clinical drug development success rate
por: Travessa, André
Publicado em: (2017)
por: Travessa, André
Publicado em: (2017)
article Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease
por: Vittori, Angelica
Publicado em: (2014)
por: Vittori, Angelica
Publicado em: (2014)
article Clinical trials corner: September 2017
por: Rodrigues, Filipe Brogueira
Publicado em: (2017)
por: Rodrigues, Filipe Brogueira
Publicado em: (2017)
article Nanotechnology to the rescue: therapeutic strategies based on brown algae for neurodegenerative diseases
por: Gonçalves, Anabela
Publicado em: (2023)
por: Gonçalves, Anabela
Publicado em: (2023)
article From the periphery to the brain: Lipocalin-2, a friend or foe?
por: Ferreira, Ana Catarina
Publicado em: (2015)
por: Ferreira, Ana Catarina
Publicado em: (2015)
article Survival, mortality, causes and places of death in a european Huntington's disease prospective cohort
por: Rodrigues, Filipe Brogueira
Publicado em: (2017)
por: Rodrigues, Filipe Brogueira
Publicado em: (2017)
article The choroid plexus in health and in disease: dialogues into and out of the brain
por: Marques, Fernanda
Publicado em: (2017)
por: Marques, Fernanda
Publicado em: (2017)
article Brain-on-a-chip: an emerging platform for studying the nanotechnology-biology interface for neurodegenerative disorders
por: Rodrigues, Raquel Oliveira
Publicado em: (2024)
por: Rodrigues, Raquel Oliveira
Publicado em: (2024)
school New in vitro model of microglia derived from human PBMCs to unravel their contribution in neurodegenerative disorders
por: Costa, Inês Sofia Tomaz da
Publicado em: (2023)
por: Costa, Inês Sofia Tomaz da
Publicado em: (2023)
article Association between periodontal disease and Alzheimer’s disease : a cross-sectional study
por: Rodrigues, Vanessa Rocha
Publicado em: (2026)
por: Rodrigues, Vanessa Rocha
Publicado em: (2026)
article Unraveling the potential of gasotransmitters as neurogenic and neuroprotective molecules: focus on Alzheimer's and Parkinson's diseases.
por: Simao, Sonia
Publicado em: (2026)
por: Simao, Sonia
Publicado em: (2026)
article Unraveling the potential of gasotransmitters as neurogenic and neuroprotective molecules: focus on Alzheimer's and Parkinson's diseases.
por: Simao, Sonia
Publicado em: (2026)
por: Simao, Sonia
Publicado em: (2026)
article Deep learning models for improving Parkinson’s disease management regarding disease stage, motor disability and quality of life
por: Gonçalves, Helena R.
Publicado em: (2025)
por: Gonçalves, Helena R.
Publicado em: (2025)
article Meta-research metrics matter : letter regarding article “indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease”
por: Rodrigues, Filipe Brogueira
Publicado em: (2017)
por: Rodrigues, Filipe Brogueira
Publicado em: (2017)
Registos relacionados
-
school Caregivers´ and healthcare professionals´ perspectives on caregivers´ burden on neurodegenerative diseases
por: Santos, Joana Filipa dos
Publicado em: (2023) -
school Use of ipscs for the treatment of neurodegenerative diseases
por: Serra, Catarina Ferreira Mendes
Publicado em: (2019) -
article Cannabidiol in neurological and neoplastic diseases: Latest developments on the molecular mechanism of action
por: Ozarowski, M.
Publicado em: (2021) -
article Caffeine and adenosine
por: Ribeiro, Joaquim A.
Publicado em: (2010) -
article Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases
por: Cano, Amanda
Publicado em: (2020)